118 related articles for article (PubMed ID: 3770041)
1. Sensitivity of the hormone dependent MXT-mouse mammary carcinoma to estradiol during tumoral growth. An autoradiographic study.
Kiss R; Paridaens R; Leclercq G; Danguy A
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):849-56. PubMed ID: 3770041
[TBL] [Abstract][Full Text] [Related]
2. Effect of castration and 17 beta-estradiol pulse on cell proliferation in the uterus and the MXT mouse mammary tumor.
Paridaens RJ; Danguy AJ; Leclercq G; Kiss R; Heuson JC
J Natl Cancer Inst; 1985 Jun; 74(6):1239-46. PubMed ID: 3858596
[TBL] [Abstract][Full Text] [Related]
3. Effect of estradiol -17- beta (E2) on cell proliferation in the uterus and the MXT mammary tumor borne by intact, ovariectomized and/or hypophysectomized mice.
de Launoit Y; Kiss R; Paridaens R; Danguy A; Pasteels JL
In Vivo; 1987; 1(3):173-9. PubMed ID: 2979783
[TBL] [Abstract][Full Text] [Related]
4. Synergism or antagonism between estradiol and progesterone on the cell kinetic parameters of the MXT mouse mammary tumor.
Kiss R; Danguy AJ; Heuson JC; Paridaens RJ
J Natl Cancer Inst; 1987 Mar; 78(3):573-9. PubMed ID: 3469468
[TBL] [Abstract][Full Text] [Related]
5. Effect of progesterone on cell proliferation in the MXT mouse hormone-sensitive mammary neoplasm.
Kiss R; Paridaens RJ; Heuson JC; Danguy AJ
J Natl Cancer Inst; 1986 Jul; 77(1):173-8. PubMed ID: 3459912
[TBL] [Abstract][Full Text] [Related]
6. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors.
Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL
Cancer Res; 1989 Jun; 49(11):2945-51. PubMed ID: 2720654
[TBL] [Abstract][Full Text] [Related]
7. Effect of prolactin and estradiol on cell proliferation in the uterus and the MXT mouse mammary neoplasm.
Kiss R; de Launoit Y; L'Hermite-Balériaux M; L'Hermite M; Paridaens RJ; Danguy AJ; Pasteels JL
J Natl Cancer Inst; 1987 May; 78(5):993-8. PubMed ID: 3472006
[TBL] [Abstract][Full Text] [Related]
8. Effect of ovariectomy, hypophysectomy and/or GnRH analog (HRF) administration on the cell proliferation of the MXT mouse hormone-dependent mammary tumor.
de Launoit Y; Kiss R; Danguy A; Paridaens R
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1443-50. PubMed ID: 3315693
[TBL] [Abstract][Full Text] [Related]
9. Effect of estradiol on proliferation and on cell loss in the MXT mouse mammary tumor.
Kiss R; Danguy A; Heuson JC; Paridaens R
Anticancer Res; 1986; 6(6):1321-8. PubMed ID: 3813488
[TBL] [Abstract][Full Text] [Related]
10. Histological staining by tritiated actinomycin D: a useful tool to study neoplastic cell heterogeneity and estrogen sensitivity of mammary tumors.
Kiss R; Leclercq G; Danguy A
Oncology; 1985; 42(2):129-32. PubMed ID: 2581200
[TBL] [Abstract][Full Text] [Related]
11. Morphology of MXT mouse mammary tumors. Correlation with growth characteristics and hormone sensitivity.
Danguy A; Kiss R; Leclercq G; Heuson JC; Pasteels JL
Eur J Cancer Clin Oncol; 1986 Jan; 22(1):69-75. PubMed ID: 3754213
[TBL] [Abstract][Full Text] [Related]
12. In vivo influence of androgens on the cell kinetics and chromatin pattern of the MXT mouse mammary tumor treated or not by aminoglutethimide.
de Launoit Y; Kiss R
J Cancer Res Clin Oncol; 1989; 115(2):129-38. PubMed ID: 2469677
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies of canine mammary tumors: influence of 17-beta-estradiol and progesterone on cell kinetics parameters.
Lespagnard L; Kiss R; Danguy A; Legros N; Lenglet G; Devleeschouwer N; Paridaens R
Oncology; 1987; 44(5):292-301. PubMed ID: 3670796
[TBL] [Abstract][Full Text] [Related]
14. Effects of combination estrogen:cyclophosphamide treatment on the growth of the MXT transplantable mammary tumor in the mouse.
Markaverich BM; Medina D; Clark JH
Cancer Res; 1983 Jul; 43(7):3208-11. PubMed ID: 6850631
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic change of the transplantable MXT mammary adenocarcinoma into mixed bone producing sarcoma-like tumors.
Kiss R; Devleeschouwer N; Paridaens RJ; Danguy A; Heuson JC; Atassi G
Anticancer Res; 1986; 6(4):753-9. PubMed ID: 3463244
[TBL] [Abstract][Full Text] [Related]
16. Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogen-dependent MXT mouse mammary cancers: correlations between growth characteristics and EGF receptor content of tumors.
Szepeshazi K; Schally AV; Halmos G; Szoke B; Groot K; Nagy A
Breast Cancer Res Treat; 1996; 40(2):129-39. PubMed ID: 8879679
[TBL] [Abstract][Full Text] [Related]
17. MXT mammary tumor treated by low dose chemotherapy. A 31P-NMR and 1H-MRI study.
Scheiber C; Kiss R; De Launoit Y; Frühling J
Anticancer Res; 1988; 8(3):403-7. PubMed ID: 2839100
[TBL] [Abstract][Full Text] [Related]
18. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
Zeller WJ; Schreiber J; Petru E; Eisenbrand G
Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
[TBL] [Abstract][Full Text] [Related]
19. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium.
Cooke PS; Buchanan DL; Young P; Setiawan T; Brody J; Korach KS; Taylor J; Lubahn DB; Cunha GR
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6535-40. PubMed ID: 9177253
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of androgen-, glucocorticoid- or estrogen-responsive growth in shionogi carcinoma 115 subline sustained in castrated mice with high dose of estrogen for 30 generations (3 years).
Fujita MQ; Yasui T; Sato B; Uchida N; Uchida K; Shiratori O; Takeda K; Matsumoto K
Jpn J Cancer Res; 1992 Sep; 83(9):995-1001. PubMed ID: 1429212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
